|
WO2006045152A1
|
|
Improved tabletting process
|
|
AU2003900126A0
|
|
Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy
|
|
AUPS167602A0
|
|
An improved modified release preparation
|
|
US6958161B2
|
|
Modified release coated drug preparation
|
|
AUPS054502A0
|
|
Composition for viral preservation
|
|
EP1671638A1
|
|
Disphosphonate solutions
|
|
AUPR485501A0
|
|
Stable injectable solutions
|
|
AU2331801A
|
|
Improved pharmaceutical compositions for poorly soluble drugs
|
|
AUPR202900A0
|
|
Protective sheath for container
|
|
AUPR018900A0
|
|
Pamidronate solution
|
|
AUPQ780600A0
|
|
Modified release formulation
|
|
AUPQ745000A0
|
|
Improved pharmaceutical compositions for poorly soluble drugs
|
|
AUPQ485499A0
|
|
Improved pharmaceutical compositions for poorly soluble drugs
|
|
AUPQ456799A0
|
|
Protective sheath for container
|
|
AUPP832499A0
|
|
Method of preventing conversion in chemical compositions
|
|
AUPP799498A0
|
|
Method of treating cancer
|
|
AUPP758298A0
|
|
Protective sheath for container
|
|
AUPP549098A0
|
|
Rectal pharmaceutical formulations
|
|
AU7015598A
|
|
Taste masked pharmaceutical compositions
|
|
AUPP229798A0
|
|
Paclitaxel and epirubicin
|
